Geode Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.44M | Buy |
|
|||||
|
2017
Q3 | $1.42M | Buy |
|
|||||
|
2017
Q2 | $1.14M | Buy |
|
|||||
|
2017
Q1 | $1.05M | Buy |
|
|||||
|
2016
Q4 | $498K | Buy |
|
|||||
|
2016
Q3 | $1.11M | Buy |
|
|||||
|
2016
Q2 | $502K | Sell |
|
|||||
|
2016
Q1 | $799 | Buy |
|
|||||
|
2015
Q4 | $1.38M | Buy |
|
|||||
|
2015
Q3 | $1.67M | Buy |
|
|||||
|
2015
Q2 | $2.25M | Buy |
|
|||||
|
2015
Q1 | $939K | Buy |
|
|||||
|
2014
Q4 | $874K | Buy |
|
|||||
|
2014
Q3 | $784K | Buy |
|
|||||
|
2014
Q2 | $1.08M | Buy |
|
|||||
|
2014
Q1 | $751K | Buy |
|
|||||
|
2013
Q4 | $371K | Buy |
|
|||||
|
2013
Q3 | $434K | Buy |
|
|||||
|
2013
Q2 | $329K | Buy |
|